Home
Categories
EXPLORE
Comedy
History
Society & Culture
Health & Fitness
News
Business
Education
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/a1/c3/7b/a1c37be5-eb30-a1de-f89c-4e68e073f38d/mza_13889544949356097047.png/600x600bb.jpg
MS MASTERS
Practical Neurology
12 episodes
2 months ago
Tune in for expert lectures on current hot topics in clinical care for MS. 
Show more...
Education
Science,
Life Sciences
RSS
All content for MS MASTERS is the property of Practical Neurology and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Tune in for expert lectures on current hot topics in clinical care for MS. 
Show more...
Education
Science,
Life Sciences
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/a1/c3/7b/a1c37be5-eb30-a1de-f89c-4e68e073f38d/mza_13889544949356097047.png/600x600bb.jpg
Guideline-Driven Strategies in MS: De-escalating and Discontinuing Disease-Modifying Therapies
MS MASTERS
13 minutes
2 months ago
Guideline-Driven Strategies in MS: De-escalating and Discontinuing Disease-Modifying Therapies
In this episode, Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, discusses the first comprehensive recommendations for de-escalating and discontinuing disease-modifying therapies in select individuals living with multiple sclerosis developed by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
MS MASTERS
Tune in for expert lectures on current hot topics in clinical care for MS.